• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于人群队列研究中C反应蛋白与良性前列腺增生/下尿路症状结局之间的关联。

Associations between C-reactive protein and benign prostatic hyperplasia/lower urinary tract symptom outcomes in a population-based cohort.

作者信息

St Sauver Jennifer L, Sarma Aruna V, Jacobson Debra J, McGree Michaela E, Lieber Michael M, Girman Cynthia J, Nehra Ajay, Jacobsen Steven J

机构信息

Division of Epidemiology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA.

出版信息

Am J Epidemiol. 2009 Jun 1;169(11):1281-90. doi: 10.1093/aje/kwp085. Epub 2009 Apr 24.

DOI:10.1093/aje/kwp085
PMID:19395697
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2727252/
Abstract

Inflammation may play a role in the development of benign prostatic hyperplasia and/or lower urinary tract symptoms (LUTS). Higher levels of C-reactive protein (CRP) may therefore be associated with the development of these outcomes. The authors examined the association of CRP levels measured in 1996 with rapid increases in prostate volume, prostate-specific antigen levels, and LUTS as well as rapid decreases in peak flow rates (through 2005) in a population-based cohort of men residing in Olmsted County, Minnesota. Men with CRP levels of > or =3.0 mg/L were more likely to have rapid increases in irritative LUTS (odds ratio (OR) = 2.14, 95% confidence interval (CI): 1.18, 3.85) and rapid decreases in peak flow rates (OR = 2.54, 95% CI: 1.09, 5.92) compared with men with CRP levels of <3.0 mg/L. CRP levels were not significantly associated with rapid increases in prostate volume, obstructive LUTS, or prostate-specific antigen levels. Associations were attenuated after adjusting for age, body mass index, hypertension, and smoking history (irritative LUTS: OR = 2.00, 95% CI: 1.04, 3.82; peak flow rate: OR = 2.45, 95% CI: 0.73, 8.25). These results suggest that rapid increases in irritative LUTS and rapid decreases in peak flow rates may be due to inflammatory processes.

摘要

炎症可能在良性前列腺增生和/或下尿路症状(LUTS)的发展中起作用。因此,较高水平的C反应蛋白(CRP)可能与这些结果的发生有关。作者在明尼苏达州奥尔姆斯特德县的一个基于人群的男性队列中,研究了1996年测量的CRP水平与前列腺体积快速增加、前列腺特异性抗原水平、LUTS以及峰值流速快速下降(至2005年)之间的关联。与CRP水平<3.0 mg/L的男性相比,CRP水平≥3.0 mg/L的男性更有可能出现刺激性LUTS快速增加(优势比(OR)=2.14,95%置信区间(CI):1.18,3.85)和峰值流速快速下降(OR = 2.54,95% CI:1.09,5.92)。CRP水平与前列腺体积快速增加、梗阻性LUTS或前列腺特异性抗原水平无显著关联。在调整年龄、体重指数、高血压和吸烟史后,关联减弱(刺激性LUTS:OR = 2.00,95% CI:1.04,3.82;峰值流速:OR = 2.45,95% CI:0.73,8.25)。这些结果表明,刺激性LUTS的快速增加和峰值流速的快速下降可能是由炎症过程引起的。

相似文献

1
Associations between C-reactive protein and benign prostatic hyperplasia/lower urinary tract symptom outcomes in a population-based cohort.基于人群队列研究中C反应蛋白与良性前列腺增生/下尿路症状结局之间的关联。
Am J Epidemiol. 2009 Jun 1;169(11):1281-90. doi: 10.1093/aje/kwp085. Epub 2009 Apr 24.
2
Invited commentary: Lower urinary tract symptoms and inflammation--weighing the evidence.特邀评论:下尿路症状与炎症——权衡证据
Am J Epidemiol. 2009 Jun 1;169(11):1291-3; discussion 1294-5. doi: 10.1093/aje/kwp084. Epub 2009 Apr 24.
3
Serum C-reactive protein levels are associated with residual urgency symptoms in patients with benign prostatic hyperplasia after medical treatment.血清 C 反应蛋白水平与良性前列腺增生患者药物治疗后残余急迫症状相关。
Urology. 2011 Dec;78(6):1373-8. doi: 10.1016/j.urology.2011.04.076. Epub 2011 Oct 2.
4
Associations between diabetes and clinical markers of benign prostatic hyperplasia among community-dwelling Black and White men.社区居住的黑人和白人男性中糖尿病与良性前列腺增生临床指标之间的关联。
Diabetes Care. 2008 Mar;31(3):476-82. doi: 10.2337/dc07-1148. Epub 2007 Dec 10.
5
Increased serum C-reactive protein level is associated with increased storage lower urinary tract symptoms in men with benign prostatic hyperplasia.血清 C 反应蛋白水平升高与良性前列腺增生男性储存期下尿路症状增加有关。
PLoS One. 2014 Jan 15;9(1):e85588. doi: 10.1371/journal.pone.0085588. eCollection 2014.
6
Associations of lower urinary tract symptoms with prostate-specific antigen levels, and screen-detected localized and advanced prostate cancer: a case-control study nested within the UK population-based ProtecT (Prostate testing for cancer and Treatment) study.下尿路症状与前列腺特异性抗原水平以及筛查发现的局限性和晚期前列腺癌的关联:一项嵌套于英国基于人群的ProtecT(前列腺癌检测与治疗)研究中的病例对照研究。
BJU Int. 2008 Nov;102(10):1400-6. doi: 10.1111/j.1464-410X.2008.07817.x. Epub 2008 Jun 6.
7
Presumed circle area ratio of the prostate in a community-based group of men.基于社区的男性群体中前列腺的假定圆形面积比。
BJU Int. 2009 Jul;104(1):58-62. doi: 10.1111/j.1464-410X.2009.08354.x. Epub 2009 Feb 11.
8
Associations between longitudinal changes in serum estrogen, testosterone, and bioavailable testosterone and changes in benign urologic outcomes.血清雌激素、睾酮和生物可利用睾酮的纵向变化与良性泌尿科结局变化之间的关联。
Am J Epidemiol. 2011 Apr 1;173(7):787-96. doi: 10.1093/aje/kwq438. Epub 2011 Mar 2.
9
Relationship among symptom score, prostate volume, and urinary flow rates in 543 patients with and without benign prostatic hyperplasia.543例有和无良性前列腺增生患者的症状评分、前列腺体积和尿流率之间的关系。
Prostate. 1998 Feb 1;34(2):121-8; discussion 129. doi: 10.1002/(sici)1097-0045(19980201)34:2<121::aid-pros6>3.0.co;2-n.
10
The relationship between lower urinary tract symptoms/benign prostatic hyperplasia and the number of components of metabolic syndrome.下尿路症状/良性前列腺增生与代谢综合征成分数量之间的关系。
Urology. 2013 Sep;82(3):674-9. doi: 10.1016/j.urology.2013.03.047. Epub 2013 Jul 11.

引用本文的文献

1
The Relationship Between Immune-Inflammatory Indexes and the Severity of Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia: A Cross-Sectional Study at a Tertiary Hospital in China.免疫炎症指标与下尿路症状/良性前列腺增生严重程度的关系:中国一家三级医院的横断面研究
J Inflamm Res. 2025 Jun 27;18:8509-8523. doi: 10.2147/JIR.S523193. eCollection 2025.
2
Association between immune-inflammatory indexes and lower urinary tract symptoms: an analysis of cross-sectional data from the US National Health and Nutrition Examination Survey (2005-2008).免疫炎症指标与下尿路症状的相关性:来自美国国家健康和营养调查(2005-2008 年)的横断面数据分析。
BMJ Open. 2024 Mar 23;14(3):e080826. doi: 10.1136/bmjopen-2023-080826.
3
The Predictive Value of the Systemic Immune-Inflammation Index for the Progression of Lower Urinary Tract Symptoms in Men.系统免疫炎症指数对男性下尿路症状进展的预测价值。
Asian Pac J Cancer Prev. 2023 Nov 1;24(11):3845-3850. doi: 10.31557/APJCP.2023.24.11.3845.
4
Association Between Neutrophil-to-Lymphocyte Ratio and Benign Prostatic Hyperplasia: Results from the TCLSIH Cohort Study.中性粒细胞与淋巴细胞比值和良性前列腺增生之间的关联:TCLSIH队列研究结果
J Inflamm Res. 2023 Oct 25;16:4857-4866. doi: 10.2147/JIR.S431049. eCollection 2023.
5
Benign Prostatic Hyperplasia and Lower Urinary Tract Symptoms: What Is the Role and Significance of Inflammation?良性前列腺增生和下尿路症状:炎症的作用和意义是什么?
Curr Urol Rep. 2019 Aug 3;20(9):54. doi: 10.1007/s11934-019-0917-1.
6
Biomarkers Implicated in Lower Urinary Tract Symptoms: Systematic Review and Pathway Analyses.生物标志物在下尿路症状中的作用:系统评价和途径分析。
J Urol. 2019 Nov;202(5):880-889. doi: 10.1097/JU.0000000000000257. Epub 2019 Oct 9.
7
Molecular pathogenesis of human prostate basal cell hyperplasia.人类前列腺基底细胞增生的分子发病机制
Prostate. 2017 May;77(13):1344-1355. doi: 10.1002/pros.23394. Epub 2017 Aug 10.
8
Association between PSA Levels and Biomarkers of Subclinical Systemic Inflammation in Middle-Aged Healthy Men from the General Population.一般人群中年健康男性前列腺特异性抗原(PSA)水平与亚临床全身炎症生物标志物之间的关联。
Curr Urol. 2016 Oct;9(3):148-152. doi: 10.1159/000442870. Epub 2016 Sep 20.
9
Lower Urinary Tract Symptoms, Depression, Anxiety and Systemic Inflammatory Factors in Men: A Population-Based Cohort Study.男性下尿路症状、抑郁、焦虑与全身炎症因子:一项基于人群的队列研究。
PLoS One. 2015 Oct 7;10(10):e0137903. doi: 10.1371/journal.pone.0137903. eCollection 2015.
10
Lower urinary tract symptoms among Caucasian-European men who have sex with men: findings from a real-life survey.与男性发生性行为的白种欧洲男性的下尿路症状:一项实际调查的结果
Prostate Cancer Prostatic Dis. 2015 Dec;18(4):376-81. doi: 10.1038/pcan.2015.41. Epub 2015 Sep 29.

本文引用的文献

1
Inflammatory Mechanisms Associated with Prostatic Inflammation and Lower Urinary Tract Symptoms.与前列腺炎症和下尿路症状相关的炎症机制
Curr Prostate Rep. 2008 May 1;6(2):67-73. doi: 10.1007/s11918-008-0011-5.
2
Obesity and C-reactive protein levels among white, black, and hispanic US adults.美国白种人、黑种人和西班牙裔成年人中的肥胖与C反应蛋白水平
Obesity (Silver Spring). 2008 Apr;16(4):875-80. doi: 10.1038/oby.2008.7. Epub 2008 Feb 7.
3
Illustrating the roles of C-reactive protein in the development of the metabolic syndrome in women--a cross-racial validation.阐明C反应蛋白在女性代谢综合征发生发展中的作用——一项跨种族验证研究
Nutr Metab Cardiovasc Dis. 2008 Dec;18(10):671-7. doi: 10.1016/j.numecd.2007.11.006. Epub 2008 Apr 1.
4
Association of C-reactive protein, interleukin-1 receptor antagonist and adiponectin with the metabolic syndrome.C反应蛋白、白细胞介素-1受体拮抗剂和脂联素与代谢综合征的关联
Mediators Inflamm. 2007;2007:93573. doi: 10.1155/2007/93573.
5
Serum C-reactive protein is an independent risk factor predicting cardiometabolic risk.血清C反应蛋白是预测心脏代谢风险的独立危险因素。
Metabolism. 2008 Feb;57(2):207-14. doi: 10.1016/j.metabol.2007.09.002.
6
Associations between diabetes and clinical markers of benign prostatic hyperplasia among community-dwelling Black and White men.社区居住的黑人和白人男性中糖尿病与良性前列腺增生临床指标之间的关联。
Diabetes Care. 2008 Mar;31(3):476-82. doi: 10.2337/dc07-1148. Epub 2007 Dec 10.
7
The long-term relationship between a real change in prostate volume and a significant change in lower urinary tract symptom severity in population-based men: the Krimpen study.基于人群的男性前列腺体积实际变化与下尿路症状严重程度显著变化之间的长期关系:克林彭研究
Eur Urol. 2008 Apr;53(4):819-25; discussion 825-7. doi: 10.1016/j.eururo.2007.08.042. Epub 2007 Aug 28.
8
Interrelationships between inflammation, C-reactive protein, and insulin resistance.炎症、C反应蛋白与胰岛素抵抗之间的相互关系。
J Cardiometab Syndr. 2006 Summer;1(3):190-6. doi: 10.1111/j.1559-4564.2006.05538.x.
9
Examination of the relationship between symptoms of prostatitis and histological inflammation: baseline data from the REDUCE chemoprevention trial.前列腺炎症状与组织学炎症之间的关系研究:REDUCE化学预防试验的基线数据
J Urol. 2007 Sep;178(3 Pt 1):896-900; discussion 900-1. doi: 10.1016/j.juro.2007.05.041. Epub 2007 Jul 16.
10
Risk of type 2 diabetes attributable to C-reactive protein and other risk factors.2型糖尿病风险归因于C反应蛋白及其他风险因素。
Diabetes Care. 2007 Oct;30(10):2695-9. doi: 10.2337/dc07-0348. Epub 2007 Jul 10.